{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T21:48:41Z","timestamp":1685224121238},"reference-count":30,"publisher":"Hindawi Limited","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":992,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1111\/ijcp.12035","type":"journal-article","created":{"date-parts":[[2012,12,13]],"date-time":"2012-12-13T18:58:53Z","timestamp":1355425133000},"page":"52-59","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Evaluation of the fibromyalgia impact questionnaire at baseline as a predictor for time to pain improvement in two clinical trials of pregabalin"],"prefix":"10.1155","volume":"67","author":[{"given":"A. G.","family":"Bushmakin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. C.","family":"Cappelleri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. B.","family":"Chandran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Zlateva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2012,12,13]]},"reference":[{"key":"10.1111\/ijcp.12035-BIB1|cit1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/art.1780380104","article-title":"The prevalence and characteristics of fibromyalgia in the general population","volume":"38","author":"Wolfe","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1111\/ijcp.12035-BIB2|cit2","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/art.1780330203","article-title":"The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee","volume":"33","author":"Wolfe","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1111\/ijcp.12035-BIB3|cit3","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pec.2008.06.005","article-title":"Patient perspectives on the impact of fibromyalgia","volume":"73","author":"Arnold","year":"2008","journal-title":"Patient Educ Couns"},{"key":"10.1111\/ijcp.12035-BIB4|cit4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1742-1241.2007.01638.x","article-title":"The health status burden of people with fibromyalgia: a review of studies that assessed health status with the SF-36 or the SF-12","volume":"62","author":"Hoffman","year":"2008","journal-title":"Int J Clin Pract"},{"key":"10.1111\/ijcp.12035-BIB5|cit5","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1472-6963-10-102","article-title":"A patient survey of the impact of fibromyalgia and the journey to diagnosis","volume":"10","author":"Choy","year":"2010","journal-title":"BMC Health Serv Res"},{"key":"10.1111\/ijcp.12035-BIB6|cit6","first-page":"184835","article-title":"The clinical concept of fibromyalgia as a changing paradigm in the past 20\u2003years","volume":"2012","author":"Fitzcharles","year":"2012","journal-title":"Pain Res Treat"},{"key":"10.1111\/ijcp.12035-BIB7|cit7","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/acr.20140","article-title":"The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity","volume":"62","author":"Wolfe","year":"2010","journal-title":"Arthritis Care Res"},{"key":"10.1111\/ijcp.12035-BIB8|cit8","doi-asserted-by":"crossref","first-page":"907","DOI":"10.4065\/mcp.2011.0206","article-title":"The science of fibromyalgia","volume":"9","author":"Clauw","year":"2011","journal-title":"Mayo Clin Proc"},{"key":"10.1111\/ijcp.12035-BIB9|cit9","first-page":"585419","article-title":"Neurobiology underlying fibromyalgia symptoms","volume":"2012","author":"Ceko","year":"2012","journal-title":"Pain Res Treat"},{"key":"10.1111\/ijcp.12035-BIB10|cit10","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1136\/ard.2007.071522","article-title":"EULAR evidence based recommendations for the management of fibromyalgia syndrome","volume":"67","author":"Carville","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/ijcp.12035-BIB11|cit11","volume-title":"Lyrica\u00ae [Pregabalin] Capsules Prescribing Information","author":"Pfizer Inc","year":"2011"},{"key":"10.1111\/ijcp.12035-BIB12|cit12","volume-title":"Cymbalta\u00ae [Duloxetine Hydrochloride] Delayed Release Capsules Prescribing Information","author":"Eli Lilly and Company","year":"2011"},{"key":"10.1111\/ijcp.12035-BIB13|cit13","volume-title":"Savella\u00ae [Milnacipran Hydrochloride] Prescribing Information","author":"Forest Pharmaceutical","year":"2009"},{"key":"10.1111\/ijcp.12035-BIB14|cit14","doi-asserted-by":"crossref","first-page":"17537","DOI":"10.1073\/pnas.0409066103","article-title":"Identification of the alpha2-delta-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin","volume":"103","author":"Field","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/ijcp.12035-BIB15|cit15","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S1059-1311(02)00295-9","article-title":"Acute effects of gabapentin and pregabalin on rat forebrain cellular GABA, glutamate, and glutamine concentrations","volume":"12","author":"Errante","year":"2003","journal-title":"Seizure"},{"key":"10.1111\/ijcp.12035-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1111\/j.1460-9568.2004.03625.x","article-title":"Dual effects of gabapentin and pregabalin on glutamate release at rat entorhinal synapses in vitro","volume":"20","author":"Cunningham","year":"2004","journal-title":"Eur J Neurosci"},{"key":"10.1111\/ijcp.12035-BIB17|cit17","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0304-3959(01)00316-5","article-title":"Gabapentin inhibits the substance P-facilitated K(+)-evoked release of [(3)H]glutamate from rat caudial trigeminal nucleus slices","volume":"93","author":"Maneuf","year":"2001","journal-title":"Pain"},{"key":"10.1111\/ijcp.12035-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/art.20983","article-title":"Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial","volume":"52","author":"Crofford","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1111\/ijcp.12035-BIB19|cit19","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jpain.2008.03.013","article-title":"A 14-week, randomized, double-blind, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia","volume":"9","author":"Arnold","year":"2008","journal-title":"J Pain"},{"key":"10.1111\/ijcp.12035-BIB20|cit20","first-page":"502","article-title":"A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia","volume":"35","author":"Mease","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1111\/ijcp.12035-BIB21|cit21","first-page":"653714","article-title":"A comprehensive evaluation of standardized assessment tools in the diagnosis of fibromyalgia and in the assessment of fibromyalgia severity","volume":"2012","author":"Boomershine","year":"2011","journal-title":"Pain Res Treat"},{"key":"10.1111\/ijcp.12035-BIB22|cit22","first-page":"728","article-title":"The fibromyalgia impact questionnaire: development and validation","volume":"18","author":"Burckhardt","year":"1991","journal-title":"J Rheumatol"},{"key":"10.1111\/ijcp.12035-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.3899\/jrheum.081090","article-title":"Minimal clinically important difference in the fibromyalgia impact questionnaire","volume":"36","author":"Bennett","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1111\/ijcp.12035-BIB24|cit24","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0304-3959(01)00349-9","article-title":"Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale","volume":"94","author":"Farrar","year":"2001","journal-title":"Pain"},{"key":"10.1111\/ijcp.12035-BIB25|cit25","doi-asserted-by":"crossref","DOI":"10.1007\/0-387-29150-4","volume-title":"Survival Analysis. A Self-Learning Text","author":"Kleinbaum","year":"2005"},{"key":"10.1111\/ijcp.12035-BIB26|cit26","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1111\/ijcp.12035-BIB27|cit27","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2307\/2529941","article-title":"General right censoring and its impact on the analysis of survival data","volume":"35","author":"Lagakos","year":"1979","journal-title":"Biometrics"},{"key":"10.1111\/ijcp.12035-BIB28|cit28","volume-title":"Lyrica\u00ae [Pregabalin] Capsules Prescribing Information","author":"Pfizer Inc","year":"2009"},{"key":"10.1111\/ijcp.12035-BIB29|cit29","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jpain.2008.05.014","article-title":"Pregabalin for postherpetic neuralgia: placebo-controlled trial of fixed and flexible dosing regimens on allodynia and time to onset of pain relief","volume":"9","author":"Stacey","year":"2008","journal-title":"J Pain"},{"key":"10.1111\/ijcp.12035-BIB30|cit30","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/MJT.0b013e3181d5e4f3","article-title":"Time to onset of neuropathic pain reduction: a retrospective analysis of data from nine controlled trials of pregabalin for painful diabetic peripheral neuropathy and postherpetic neuralgia","volume":"17","author":"Sharma","year":"2010","journal-title":"Am J Ther"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fijcp.12035","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T06:06:24Z","timestamp":1643349984000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ijcp.12035"}},"subtitle":["Time to meaningful pain reduction"],"short-title":[],"issued":{"date-parts":[[2012,12,13]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"URL":"https:\/\/doi.org\/10.1111\/ijcp.12035","relation":{},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12,13]]},"assertion":[{"value":"2012-12-13","name":"published_online","label":"Published Online","group":{"name":"publication_history","label":"Publication History"}}]}}